An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in MPS II (Hunter Syndrome) Subjects

NCT05594992 · clinicaltrials.gov ↗

PHASE3

Phase

ENROLLING_BY_INVITATION

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Mucopolysaccharidosis II

Interventions

DRUG: JR-141

Sponsor

JCR Pharmaceuticals Co., Ltd.